BioCorRx Inc. (BICX) › Cost of RevenueBioCorRx Inc. (BICX) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2013: $160.2K2014: $221.0K2015: $152.0K2016: $175.4K2017: $323.6K2018: $171.0K2019: $81.7K2020: $95.9K2021: $5.9K2022: $15.3K2023: $36.0K2024: $1.7K$1.7K2013Cost of Revenue (USD)2024Fiscal YearCost of RevenueChange YoY2024$1.7K-95.4%2023$36.0K+135.5%2022$15.3K+159.8%2021$5.9K-93.9%2020$95.9K+17.5%2019$81.7K-52.2%2018$171.0K-47.2%2017$323.6K+84.5%2016$175.4K+15.4%2015$152.0K-31.2%2014$221.0K+37.9%2013$160.2K—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share